Tolero Pharmaceuticals Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 20

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 5

Tolero Pharmaceuticals General Information

Description

Developer of therapeutics for the treatment of cancer and other diseases created to improving lives of people with serious diseases. The company's therapeutics treatment focuses in the areas of oncology and hematological disorders by developing new therapeutics on a dramatically shortened time-frame and at a much lower cost than traditional drug development, helping patients reduce suffering.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 2975 Executive Parkway
  • Suite 320
  • Lehi, UT 84043
  • United States
Primary Industry
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
  • 2975 Executive Parkway
  • Suite 320
  • Lehi, UT 84043
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tolero Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Tolero Pharmaceuticals‘s full profile, request access.

Request a free trial

Tolero Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of therapeutics for the treatment of cancer and other diseases created to improving lives of people with serio
Drug Discovery
Lehi, UT
20 As of 2016

Lexington, MA
 

Basel, Switzerland
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tolero Pharmaceuticals Competitors (50)

One of Tolero Pharmaceuticals’s 50 competitors is Voyager Therapeutics, a Formerly VC-backed company based in Lexington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Voyager Therapeutics Formerly VC-backed Lexington, MA
Baliopharm Venture Capital-Backed Basel, Switzerland
Centrose Venture Capital-Backed Madison, WI
FoRx Therapeutics Venture Capital-Backed Basel, Switzerland
Agios Pharmaceuticals Formerly VC-backed Cambridge, MA
You’re viewing 5 of 50 competitors. Get the full list »

Tolero Pharmaceuticals Patents

Tolero Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11793802-B2 Treatment of acute myeloid leukemia (aml) with venetoclax failure Active 20-Mar-2019
US-20220125776-A1 Treatment of acute myeloid leukemia (aml) with venetoclax failure Active 20-Mar-2019
WO-2020167990-A1 Formulations comprising heterocyclic protein kinase inhibitors Inactive 12-Feb-2019
WO-2020146819-A1 Alk5 inhibitors for treating myelodysplastic syndrome Inactive 10-Jan-2019
WO-2020118252-A1 Methods for treating castration-resistant and castration- sensitive prostate cancer Inactive 07-Dec-2018 A61K31/675
To view Tolero Pharmaceuticals’s complete patent history, request access »

Tolero Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tolero Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Tolero Pharmaceuticals‘s full profile, request access.

Request a free trial

Tolero Pharmaceuticals FAQs

  • When was Tolero Pharmaceuticals founded?

    Tolero Pharmaceuticals was founded in 2011.

  • Where is Tolero Pharmaceuticals headquartered?

    Tolero Pharmaceuticals is headquartered in Lehi, UT.

  • What is the size of Tolero Pharmaceuticals?

    Tolero Pharmaceuticals has 20 total employees.

  • What industry is Tolero Pharmaceuticals in?

    Tolero Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Tolero Pharmaceuticals a private or public company?

    Tolero Pharmaceuticals is a Private company.

  • What is the current valuation of Tolero Pharmaceuticals?

    The current valuation of Tolero Pharmaceuticals is .

  • What is Tolero Pharmaceuticals’s current revenue?

    The current revenue for Tolero Pharmaceuticals is .

  • How much funding has Tolero Pharmaceuticals raised over time?

    Tolero Pharmaceuticals has raised $22.4M.

  • Who are Tolero Pharmaceuticals’s investors?

    Alger, Astex Pharmaceuticals, Black Cliffs Partners, and Orelot have invested in Tolero Pharmaceuticals.

  • Who are Tolero Pharmaceuticals’s competitors?

    Voyager Therapeutics, Baliopharm, Centrose, FoRx Therapeutics, and Agios Pharmaceuticals are some of the 50 competitors of Tolero Pharmaceuticals.

  • When was Tolero Pharmaceuticals acquired?

    Tolero Pharmaceuticals was acquired on 31-Mar-2017.

  • Who acquired Tolero Pharmaceuticals?

    Tolero Pharmaceuticals was acquired by Sumitomo Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process